231 related articles for article (PubMed ID: 24090228)
1. A randomized controlled trial of venlafaxine XR for major depressive disorder after spinal cord injury: Methods and lessons learned.
Bombardier CH; Fann JR; Wilson CS; Heinemann AW; Richards JS; Warren AM; Brooks L; Warms CA; Temkin NR; Tate DG
J Spinal Cord Med; 2014 May; 37(3):247-63. PubMed ID: 24090228
[TBL] [Abstract][Full Text] [Related]
2. Venlafaxine extended-release for depression following spinal cord injury: a randomized clinical trial.
Fann JR; Bombardier CH; Richards JS; Wilson CS; Heinemann AW; Warren AM; Brooks L; McCullumsmith CB; Temkin NR; Warms C; Tate DG;
JAMA Psychiatry; 2015 Mar; 72(3):247-58. PubMed ID: 25607727
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial.
Richards JS; Bombardier CH; Wilson CS; Chiodo AE; Brooks L; Tate DG; Temkin NR; Barber JK; Heinemann AW; McCullumsmith C; Fann JR
Arch Phys Med Rehabil; 2015 Apr; 96(4):680-9. PubMed ID: 25527253
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Psychometric Properties and Responsiveness to Change of 3 Depression Measures in a Sample of Persons With Traumatic Spinal Cord Injury and Major Depressive Disorder.
Williams RT; Heinemann AW; Neumann HD; Fann JR; Forchheimer M; Richardson EJ; Bombardier CH;
Arch Phys Med Rehabil; 2016 Jun; 97(6):929-37. PubMed ID: 26859610
[TBL] [Abstract][Full Text] [Related]
5. A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders.
Levin FR; Mariani J; Brooks DJ; Pavlicova M; Nunes EV; Agosti V; Bisaga A; Sullivan MA; Carpenter KM
Addiction; 2013 Jun; 108(6):1084-94. PubMed ID: 23297841
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
7. Depression after spinal cord injury and medication: The journey continues.
Hough S
J Spinal Cord Med; 2014 May; 37(3):246. PubMed ID: 24617509
[No Abstract] [Full Text] [Related]
8. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the relationship of spiritual well-being to depression and quality of life for persons with spinal cord injury.
Wilson CS; Forchheimer M; Heinemann AW; Warren AM; McCullumsmith C
Disabil Rehabil; 2017 Mar; 39(5):491-496. PubMed ID: 27109856
[TBL] [Abstract][Full Text] [Related]
10. Differences in quality of life outcomes among depressed spinal cord injury trial participants.
Tate DG; Forchheimer M; Bombardier CH; Heinemann AW; Neumann HD; Fann JR
Arch Phys Med Rehabil; 2015 Feb; 96(2):340-8. PubMed ID: 25450124
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.
Thase M; Asami Y; Wajsbrot D; Dorries K; Boucher M; Pappadopulos E
Curr Med Res Opin; 2017 Feb; 33(2):317-326. PubMed ID: 27794623
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release and a long-term extension study for patients with major depressive disorder in Japan.
Higuchi T; Kamijima K; Nakagome K; Itamura R; Asami Y; Kuribayashi K; Imaeda T
Int Clin Psychopharmacol; 2016 Jan; 31(1):8-19. PubMed ID: 26513202
[TBL] [Abstract][Full Text] [Related]
13. Effect of venlafaxine on anhedonia and amotivation in patients with major depressive disorder.
McIntyre RS; Agid O; Biesheuvel E; Purushottamahanti P
CNS Spectr; 2024 Jun; 29(3):206-214. PubMed ID: 38685594
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive Disorder.
Ye W; Zhao Y; Robinson RL; Swindle RW
BMC Psychiatry; 2011 Jan; 11():19. PubMed ID: 21281479
[TBL] [Abstract][Full Text] [Related]
15. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
Wang G; Gislum M; Filippov G; Montgomery S
Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine extended-release: a review of its use in the management of major depression.
Wellington K; Perry CM
CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depression.
Rudolph RL; Feiger AD
J Affect Disord; 1999 Dec; 56(2-3):171-81. PubMed ID: 10701474
[TBL] [Abstract][Full Text] [Related]
18. [Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].
Olié JP; Gourion D; Montagne A; Rostin M; Poirier MF
Encephale; 2009 Dec; 35(6):595-604. PubMed ID: 20004291
[TBL] [Abstract][Full Text] [Related]
19. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
20. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group.
Cunningham LA
Ann Clin Psychiatry; 1997 Sep; 9(3):157-64. PubMed ID: 9339881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
